Cytokinetics (CYTK) Tax Provisions (2010)

Cytokinetics (CYTK) posted quarterly Tax Provisions of -$176000.0 for Q3 2010.

Cytokinetics (CYTK) Tax Provisions (2010) Analysis & Trends

Cytokinetics (CYTK) has reported Tax Provisions for 1 consecutive years, with -$176000.0 the latest figure, recorded in Q3 2010.

In Q3 2010, Tax Provisions changed N/A year-over-year to -$176000.0; the TTM figure through Jun 2014 stood at -$176000.0 (changed N/A YoY), while the FY2010 annual figure was -$176000.0, down 217.33% from the prior year.
Tax Provisions held at -$176000.0 in Q3 2010 per CYTK's latest filing.
Across five years, Tax Provisions topped out at -$176000.0 in Q3 2010 and bottomed at -$176000.0 in Q3 2010.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	59.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	75.45 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	267.73
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	13.31 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.90 Mn
10	Cytokinetics	10.31 Bn	9.14 Bn	25.89 Mn	-

Historic Data

Download Data

Date	Value
Sep 30, 2010	-176,000.00